Polatuzumab vedotin [1313206-42-6]

TargetMol Chemicals

Polatuzumab vedotin

9

1313206-42-6

Chemical

Research Use Only

Polatuzumab vedotin

Polatuzumab vedotin, an antibody-drug conjugate, selectively targets CD79b with a humanized anti-CD79b IgG1 monoclonal antibody bound to monomethyl auristatin E (MMAE), a robust microtubule inhibitor. This compound shows promise for research into Large B-cell lymphomas (LBCL) [1].

3 years

-20°C

12352203